Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma

Bibliographic Details
Title: Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma
Authors: Hong Xiao, Hangyu Chen, Lei Zhang, Maimaitiyasen Duolikun, Baixin Zhen, Subinuer Kuerban, Xuehui Li, Yuxi Wang, Long Chen, Jian Lin
Source: World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-16 (2024)
Publisher Information: BMC, 2024.
Publication Year: 2024
Collection: LCC:Surgery
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: KAS-seq, Hepatocellular carcinoma, Sorafenib, Drug resistance, Cytoskeleton, Surgery, RD1-811, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Background Although sorafenib has been consistently used as a first-line treatment for advanced hepatocellular carcinoma (HCC), most patients will develop resistance, and the mechanism of resistance to sorafenib needs further study. Methods Using KAS-seq technology, we obtained the ssDNA profiles within the whole genome range of SMMC-7721 cells treated with sorafenib for differential analysis. We then intersected the differential genes obtained from the analysis of hepatocellular carcinoma patients in GSE109211 who were ineffective and effective with sorafenib treatment, constructed a PPI network, and obtained hub genes. We then analyzed the relationship between the expression of these genes and the prognosis of hepatocellular carcinoma patients. Results In this study, we identified 7 hub ERGs (ACTB, CFL1, ACTG1, ACTN1, WDR1, TAGLN2, HSPA8) related to drug resistance, and these genes are associated with the cytoskeleton. Conclusions The cytoskeleton is associated with sorafenib resistance in hepatocellular carcinoma. Using KAS-seq to analyze the early changes in tumor cells treated with drugs is feasible for studying the drug resistance of tumors, which provides reference significance for future research.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1477-7819
Relation: https://doaj.org/toc/1477-7819
DOI: 10.1186/s12957-024-03417-2
Access URL: https://doaj.org/article/95c8c21c66244d4c884a3775333c0344
Accession Number: edsdoj.95c8c21c66244d4c884a3775333c0344
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:14777819
DOI:10.1186/s12957-024-03417-2
Published in:World Journal of Surgical Oncology
Language:English